Mr Luca List

Vienna (Austria)

Follow

Contributor content

The PA/Ao ratio as a predictor for adverse outcomes in light-chain vs. transthyretin cardiac amyloidosis

Presentation

The PA/Ao ratio as a predictor for adverse outcomes in light-chain vs. transthyretin cardiac amyloidosis

ESC 365 is supported by

novartis

Explore sponsored resources